Jinyu Bio-Technology Co Ltd (600201) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jinyu Bio-Technology Co Ltd (600201) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥102.68 Million ≈ $15.03 Million USD) by net assets (CN¥5.65 Billion ≈ $827.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600201 market cap for the company's overall valuation and market capitalisation.
Jinyu Bio-Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Jinyu Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jinyu Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jinyu Bio-Technology Co Ltd ranked by their cash flow conversion efficiency. Explore 600201 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
A.F.P. Provida
SN:PROVIDA
|
0.022x |
|
Galapagos NV ADR
NASDAQ:GLPG
|
-0.025x |
|
Eastern Communications Co Ltd A
SHG:600776
|
-0.006x |
|
Luenmei Quantum Co Ltd
SHG:600167
|
0.009x |
|
Target Hospitality Corp
NASDAQ:TH
|
0.281x |
|
L&F Co. Ltd
KQ:066970
|
0.167x |
|
Hubei Yihua Chemical Industry Co Ltd
SHE:000422
|
0.124x |
|
Sichuan Expressway Co Ltd
SHG:601107
|
0.051x |
Annual Cash Flow Conversion Efficiency for Jinyu Bio-Technology Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Jinyu Bio-Technology Co Ltd from 1998 to 2025. View today's stock price for Jinyu Bio-Technology Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.55 Billion ≈ $812.27 Million |
CN¥316.12 Million ≈ $46.26 Million |
0.057x | +6.51% |
| 2024-12-31 | CN¥5.42 Billion ≈ $792.44 Million |
CN¥289.55 Million ≈ $42.37 Million |
0.053x | -27.11% |
| 2023-12-31 | CN¥5.65 Billion ≈ $827.50 Million |
CN¥414.83 Million ≈ $60.70 Million |
0.073x | +13.87% |
| 2022-12-31 | CN¥5.35 Billion ≈ $782.82 Million |
CN¥344.65 Million ≈ $50.43 Million |
0.064x | -32.80% |
| 2021-12-31 | CN¥5.56 Billion ≈ $813.64 Million |
CN¥533.08 Million ≈ $78.01 Million |
0.096x | -27.88% |
| 2020-12-31 | CN¥5.26 Billion ≈ $770.13 Million |
CN¥699.61 Million ≈ $102.38 Million |
0.133x | +59.72% |
| 2019-12-31 | CN¥4.87 Billion ≈ $712.50 Million |
CN¥405.24 Million ≈ $59.30 Million |
0.083x | +2.89% |
| 2018-12-31 | CN¥5.22 Billion ≈ $764.23 Million |
CN¥422.46 Million ≈ $61.82 Million |
0.081x | -59.37% |
| 2017-12-31 | CN¥4.48 Billion ≈ $655.26 Million |
CN¥891.44 Million ≈ $130.45 Million |
0.199x | -1.20% |
| 2016-12-31 | CN¥3.75 Billion ≈ $549.13 Million |
CN¥756.12 Million ≈ $110.64 Million |
0.201x | -15.68% |
| 2015-12-31 | CN¥2.07 Billion ≈ $302.70 Million |
CN¥494.32 Million ≈ $72.33 Million |
0.239x | -33.42% |
| 2014-12-31 | CN¥1.63 Billion ≈ $238.59 Million |
CN¥585.19 Million ≈ $85.63 Million |
0.359x | -29.15% |
| 2013-12-31 | CN¥1.28 Billion ≈ $187.57 Million |
CN¥649.34 Million ≈ $95.02 Million |
0.507x | +430.26% |
| 2012-12-31 | CN¥1.08 Billion ≈ $157.69 Million |
CN¥102.95 Million ≈ $15.06 Million |
0.096x | -48.88% |
| 2011-12-31 | CN¥991.13 Million ≈ $145.03 Million |
CN¥185.20 Million ≈ $27.10 Million |
0.187x | +264.74% |
| 2010-12-31 | CN¥844.15 Million ≈ $123.53 Million |
CN¥-95.75 Million ≈ $-14.01 Million |
-0.113x | -247.73% |
| 2009-12-31 | CN¥750.98 Million ≈ $109.89 Million |
CN¥-24.50 Million ≈ $-3.58 Million |
-0.033x | -110.54% |
| 2008-12-31 | CN¥723.47 Million ≈ $105.87 Million |
CN¥223.91 Million ≈ $32.77 Million |
0.309x | +61.13% |
| 2007-12-31 | CN¥708.54 Million ≈ $103.68 Million |
CN¥136.09 Million ≈ $19.91 Million |
0.192x | +13.34% |
| 2006-12-31 | CN¥605.80 Million ≈ $88.65 Million |
CN¥102.66 Million ≈ $15.02 Million |
0.169x | +245.73% |
| 2005-12-31 | CN¥577.16 Million ≈ $84.46 Million |
CN¥28.29 Million ≈ $4.14 Million |
0.049x | -63.17% |
| 2004-12-31 | CN¥609.02 Million ≈ $89.12 Million |
CN¥81.06 Million ≈ $11.86 Million |
0.133x | +249.67% |
| 2003-12-31 | CN¥573.94 Million ≈ $83.99 Million |
CN¥-51.04 Million ≈ $-7.47 Million |
-0.089x | -149.42% |
| 2002-12-31 | CN¥529.82 Million ≈ $77.53 Million |
CN¥95.34 Million ≈ $13.95 Million |
0.180x | +369.42% |
| 2001-12-31 | CN¥517.19 Million ≈ $75.68 Million |
CN¥-34.55 Million ≈ $-5.06 Million |
-0.067x | -123.55% |
| 2000-12-31 | CN¥344.80 Million ≈ $50.45 Million |
CN¥97.80 Million ≈ $14.31 Million |
0.284x | +410.31% |
| 1999-12-31 | CN¥334.58 Million ≈ $48.96 Million |
CN¥-30.58 Million ≈ $-4.48 Million |
-0.091x | +14.83% |
| 1998-12-31 | CN¥333.06 Million ≈ $48.74 Million |
CN¥-35.74 Million ≈ $-5.23 Million |
-0.107x | -- |
About Jinyu Bio-Technology Co Ltd
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary biological products in China and internationally. The company's products focus on preventing porcine mycoplasmal pneumonia, pseudorabies, highly pathogenic avian influenza, brucellosis, and other Class I, II, and III animal diseases. It also provides pig vaccines, swine foot-and-mouth diseas… Read more